Stockscreener 앱 받기
7.44
5.68%
0.40
시간 외 거래:
7.42
-0.02
-0.27%
전일 마감가:
$7.04
열려 있는:
$7.07
하루 거래량:
3.61M
Relative Volume:
2.36
시가총액:
$762.09M
수익:
$187.64M
순이익/손실:
$-95.00M
주가수익비율:
-7.8316
EPS:
-0.95
순현금흐름:
$-69.02M
1주 성능:
-0.67%
1개월 성능:
+5.53%
6개월 성능:
-4.37%
1년 성능:
-49.46%
1일 변동 폭
$6.97
$7.53
1주일 범위
$6.90
$7.86
52주 변동 폭
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
명칭
Day One Biopharmaceuticals Inc
전화
650 484-0899
주소
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
DAWN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.44 | 721.12M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-10-09 | 재확인 | Needham | Buy |
| 2024-08-01 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-04-24 | 재확인 | Needham | Buy |
| 2023-04-25 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-08 | 개시 | CapitalOne | Overweight |
| 2023-02-03 | 개시 | Oppenheimer | Perform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-12-14 | 개시 | Needham | Buy |
| 2022-12-05 | 개시 | Goldman | Buy |
| 2022-12-01 | 개시 | BofA Securities | Buy |
모두보기
Day One Biopharmaceuticals Inc 주식(DAWN)의 최신 뉴스
Will Day One Biopharmaceuticals Inc. price bounce be sustainableBuy Signal & Real-Time Volume Surge Alerts - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Quarterly Growth Report & Daily Oversold Stock Bounce Ideas - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Will Day One Biopharmaceuticals Inc. stock remain a Wall Street favoritePortfolio Performance Summary & Expert Verified Movement Alerts - newser.com
Y Intercept Hong Kong Ltd Invests $1.83 Million in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Pattern recognition hints at Day One Biopharmaceuticals Inc. upsideTrade Analysis Report & Weekly Momentum Picks - newser.com
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stockJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Day One Biopharmaceuticals Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Day One Biopharmaceuticals (NASDAQ:DAWN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Day One Biopharmaceuticals Inc. stock outlook for YEARJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
How Day One Biopharmaceuticals Inc. stock benefits from global expansionPortfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com
Why Day One Biopharmaceuticals Inc. stock attracts global investors2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
What does recent volatility data suggest for Day One Biopharmaceuticals Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options data2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Market reaction to Day One Biopharmaceuticals Inc.’s recent news2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Multi factor analysis applied to Day One Biopharmaceuticals Inc.2025 Big Picture & Safe Entry Momentum Tips - newser.com
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? - sharewise.com
Day One Biopharmaceuticals Advances Cancer Treatment with DAY301 Study - MSN
Can Day One Biopharmaceuticals Inc. rally from current levels2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Day One Biopharmaceuticals Advances Pediatric Cancer Study with Promising Drug Tovorafenib - The Globe and Mail
Day One Biopharmaceuticals (NASDAQ:DAWN) Is In A Strong Position To Grow Its Business - Yahoo Finance
Day One Biopharmaceuticals Inc (DAWN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):